478 related articles for article (PubMed ID: 28331305)
21. Upper respiratory symptoms worsen over time and relate to clinical phenotype in chronic obstructive pulmonary disease.
Huerta A; Donaldson GC; Singh R; Mackay AJ; Allinson JP; Brill SE; Kowlessar B; Torres A; Wedzicha JA
Ann Am Thorac Soc; 2015 Jul; 12(7):997-1004. PubMed ID: 25938279
[TBL] [Abstract][Full Text] [Related]
22. Usefulness of the Chronic Obstructive Pulmonary Disease Assessment Test to evaluate severity of COPD exacerbations.
Mackay AJ; Donaldson GC; Patel AR; Jones PW; Hurst JR; Wedzicha JA
Am J Respir Crit Care Med; 2012 Jun; 185(11):1218-24. PubMed ID: 22281834
[TBL] [Abstract][Full Text] [Related]
23. A score to predict short-term risk of COPD exacerbations (SCOPEX).
Make BJ; Eriksson G; Calverley PM; Jenkins CR; Postma DS; Peterson S; Östlund O; Anzueto A
Int J Chron Obstruct Pulmon Dis; 2015; 10():201-9. PubMed ID: 25670896
[TBL] [Abstract][Full Text] [Related]
24. Inflammatory biomarkers and exacerbations in chronic obstructive pulmonary disease.
Thomsen M; Ingebrigtsen TS; Marott JL; Dahl M; Lange P; Vestbo J; Nordestgaard BG
JAMA; 2013 Jun; 309(22):2353-61. PubMed ID: 23757083
[TBL] [Abstract][Full Text] [Related]
25. Detection and severity grading of COPD exacerbations using the exacerbations of chronic pulmonary disease tool (EXACT).
Mackay AJ; Donaldson GC; Patel AR; Singh R; Kowlessar B; Wedzicha JA
Eur Respir J; 2014 Mar; 43(3):735-44. PubMed ID: 23988767
[TBL] [Abstract][Full Text] [Related]
26. C-reactive protein in outpatients with acute exacerbation of COPD: its relationship with microbial etiology and severity.
Gallego M; Pomares X; Capilla S; Marcos MA; Suárez D; Monsó E; Montón C
Int J Chron Obstruct Pulmon Dis; 2016; 11():2633-2640. PubMed ID: 27799762
[TBL] [Abstract][Full Text] [Related]
27. Detection of adenovirus and respiratory syncytial virus in patients with chronic obstructive pulmonary disease: Exacerbation versus stable condition.
Kokturk N; Bozdayi G; Yilmaz S; Doğan B; Gulbahar O; Rota S; Tatlicioglu T
Mol Med Rep; 2015 Aug; 12(2):3039-46. PubMed ID: 25936369
[TBL] [Abstract][Full Text] [Related]
28. Frequency and risk factors of COPD exacerbations and hospitalizations: a nationwide study in Greece (Greek Obstructive Lung Disease Epidemiology and health ecoNomics: GOLDEN study).
Alexopoulos EC; Malli F; Mitsiki E; Bania EG; Varounis C; Gourgoulianis KI
Int J Chron Obstruct Pulmon Dis; 2015; 10():2665-74. PubMed ID: 26715845
[TBL] [Abstract][Full Text] [Related]
29. Wheezing, a significant clinical phenotype of COPD: experience from the Taiwan Obstructive Lung Disease Study.
Huang WC; Tsai YH; Wei YF; Kuo PH; Tao CW; Cheng SL; Lee CH; Wu YK; Chen NH; Hsu WH; Hsu JY; Wang CC; Lin MS
Int J Chron Obstruct Pulmon Dis; 2015; 10():2121-6. PubMed ID: 26504377
[TBL] [Abstract][Full Text] [Related]
30. The association between daily exacerbation symptoms and physical activity in patients with chronic obstructive pulmonary disease.
Crook S; Büsching G; Keusch S; Wieser S; Turk A; Frey M; Puhan MA; Frei A
Int J Chron Obstruct Pulmon Dis; 2018; 13():2199-2206. PubMed ID: 30140152
[TBL] [Abstract][Full Text] [Related]
31. Predictors of Hospitalized Exacerbations and Mortality in Chronic Obstructive Pulmonary Disease.
Santibáñez M; Garrastazu R; Ruiz-Nuñez M; Helguera JM; Arenal S; Bonnardeux C; León C; García-Rivero JL
PLoS One; 2016; 11(6):e0158727. PubMed ID: 27362765
[TBL] [Abstract][Full Text] [Related]
32. 'Exacerbation-free time' to assess the impact of exacerbations in patients with chronic obstructive pulmonary disease (COPD): a prospective observational study.
Boer LM; Bischoff EW; Borgijink X; Vercoulen JH; Akkermans RP; Kerstjens HAM; Assendelft WJ; Schermer TR
NPJ Prim Care Respir Med; 2018 Apr; 28(1):12. PubMed ID: 29615628
[TBL] [Abstract][Full Text] [Related]
33. Prevalence and Risk Factors of Respiratory Viral Infections in Exacerbations of Chronic Obstructive Pulmonary Disease.
Kwak HJ; Park DW; Kim JE; Park MK; Koo GW; Park TS; Moon JY; Kim TH; Sohn JW; Yoon HJ; Shin DH; Kim SH
Tohoku J Exp Med; 2016 Oct; 240(2):131-139. PubMed ID: 27725531
[TBL] [Abstract][Full Text] [Related]
34. The impact of using different symptom-based exacerbation algorithms in patients with COPD.
Trappenburg JC; van Deventer AC; Troosters T; Verheij TJ; Schrijvers AJ; Lammers JW; Monninkhof EM
Eur Respir J; 2011 May; 37(5):1260-8. PubMed ID: 21177839
[TBL] [Abstract][Full Text] [Related]
35. Factors influencing exacerbation-related self-management in patients with COPD: a qualitative study.
Korpershoek Y; Vervoort S; Nijssen L; Trappenburg J; Schuurmans MJ
Int J Chron Obstruct Pulmon Dis; 2016; 11():2977-2990. PubMed ID: 27932877
[TBL] [Abstract][Full Text] [Related]
36. Characterizing and quantifying the symptomatic features of COPD exacerbations.
Jones PW; Chen WH; Wilcox TK; Sethi S; Leidy NK;
Chest; 2011 Jun; 139(6):1388-1394. PubMed ID: 21071529
[TBL] [Abstract][Full Text] [Related]
37. Drop in lung function during asthma and COPD exacerbations - can it be assessed without spirometry?
Melbye H; Al-Ani S; Spigt M
Int J Chron Obstruct Pulmon Dis; 2016; 11():3145-3152. PubMed ID: 27994453
[TBL] [Abstract][Full Text] [Related]
38. COPD exacerbations: definitions and classifications.
Burge S; Wedzicha JA
Eur Respir J Suppl; 2003 Jun; 41():46s-53s. PubMed ID: 12795331
[TBL] [Abstract][Full Text] [Related]
39. Effects of roflumilast in COPD patients receiving inhaled corticosteroid/long-acting β2-agonist fixed-dose combination: RE(2)SPOND rationale and study design.
Rennard SI; Martinez FJ; Rabe KF; Sethi S; Pizzichini E; McIvor A; Siddiqui S; Anzueto A; Zhu H
Int J Chron Obstruct Pulmon Dis; 2016; 11():1921-8. PubMed ID: 27574416
[TBL] [Abstract][Full Text] [Related]
40. Independent effect of depression and anxiety on chronic obstructive pulmonary disease exacerbations and hospitalizations.
Xu W; Collet JP; Shapiro S; Lin Y; Yang T; Platt RW; Wang C; Bourbeau J
Am J Respir Crit Care Med; 2008 Nov; 178(9):913-20. PubMed ID: 18755925
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
